Table 1 Basic characteristics of patients included in the study(SVATS/IVATS)
Study Atuhor | Year | Country | Stage | Number of patients | Age | BMI | Size |
|---|---|---|---|---|---|---|---|
Zhengcheng Liu | 2020 | China | I, II | 76/217 | 49.8 ± 9.2/51.3 ± 10.2 | 23.1 ± 2.9/23.9 ± 3.2 | 3.2 ± 1.8/3.5 ± 2.1 |
Peng Shen | 2021 | China | I, II | 45/45 | 65.21 ± 1.23/65.23 ± 1.22 | 25.37 ± 1.59/25.42 ± 1.61 | 4.05 ± 1.41/ 4.11 ± 1.35 |
Bin Li | 2022 | China | I, II | 99/246 | 49.05 ± 12.56/50.69 ± 13.89 | 24.35 ± 3.48/24.26 ± 3.90 | 3.74 ± 0.76/3.72 ± 1.09 |
Xinyu Yang | 2022 | China | I, II | 268/193 | 54.1 ± 12.6/56.2 ± 11.7 | 22.8 ± 2.4 /23.1 ± 2.3 | 4.9 ± 2.3/4.9 ± 2.7 |
Louqian Zhang | 2019 | China | I, II | 28/70 | 58.2 ± 10.0/54.8 ± 8.6 | 22.7 ± 3.8/ 23.4 ± 2.6 | 3.2 ± 1.6/3.6 ± 1.3 |
Long Jiang | 2021 | China | I,II | 39/198 | 48 ± 14/47 ± 14 | 23.2 ± 3.1/23.1 ± 3.3 | 6.7 ± 2.9/5.9 ± 2.8 |
Wang H | 2017 | China | Early stage | 36/47 | - | - | - |